Nevada Cancer Research Foundation CCOP
601 South Rancho Drive Suite C-26
Las Vegas, Nevada 89106
(702) 384-0013 http://www.sncrf.org

Use our guide to learn which trials are right for you!

The Nevada Cancer Research Foundation Community Clinical Oncology Program (NCRF-CCOP) has been funded as a CCOP by NCI since the inception of the program in 1983. There have been many changes and much growth since then.

The NCRF-CCOP was initiated as a free-standing, non-hospital based CCOP, in order to better serve the Las Vegas community as a non-partisan entity. Its founding members consisted of three medical oncologists, two radiation oncologists, two local hospitals, and a handful of physicians from various supporting specialties. The NCRF-CCOP membership has grown to include over 75 hematologists, oncologists and radiation oncologists within 10 physician practice groups and five affiliate hospitals that encompass the entire state of Nevada. Overall, approximately 90 % of the oncologists, hematologists and radiation oncologists living in the state of Nevada are part of the NCRF-CCOP program.

The NCRF-CCOP investigators and staff are multidisciplinary professionals committed to enrolling patients on NCI clinical trials. The main NCRF-CCOP office continues as a free-standing, non-hospital based institution located in Las Vegas where most of the population is located. Adult and pediatric patients in the Las Vegas metropolitan area are offered the opportunity to participate in treatment, cancer control and prevention and biology studies. Each of the three hospitals in the north has provided a research office and staff to provide regulatory and data management support for the northern physicians as they see patients in the hospitals and in their private offices. Adult patients in the Carson City/Reno area are offered the opportunity to participate in treatment, cancer control, prevention and biology studies.

We've found
13 trials
at this facility
Oncology Clinical Trial
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Status: Enrolling
Updated: 7/22/2013
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Musculoskeletal, Neurology, Oncology, Psychiatry / Psychology, Other Clinical Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 2/3/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Melanoma Clinical Trial
S1320: Intermittent Versus Continuous Dosing of Dabrafenib and Trametinib in BRAFV600E/K Mutant Melanoma
Status: Enrolling, Phase II
Updated: 7/23/2014
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Colorectal Neoplasms Clinical Trial
S0820, Adenoma and Second Primary Prevention Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
Status: Enrolling
Updated: 4/5/2011
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling, Phase II
Updated: 10/7/2013
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Status: Enrolling
Updated: 12/30/2011
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials